title: Apnea in the newborn.
abstract: Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation, is a common occurrence in sick neonates. Apnea is a common manifestation of various etiologies in sick neonates. In preterm children it may be related to the immaturity of the central nervous system. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylaxanthines and Continuous Positive Airway Pressure form the mainstay of treatment of apnea in neonates. Mechanical ventilation is reserved for apnea resistant to above therapy. An approach to the management of apnea in neonates has been described.
authors.affiliation: Division of Neonatology, Department of Pediatrics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
authors.forename: R
authors.initials: R
authors.lastname: Aggarwal
authors.forename: A
authors.initials: A
authors.lastname: Singhal
authors.forename: A K
authors.initials: AK
authors.lastname: Deorari
authors.forename: V K
authors.initials: VK
authors.lastname: Paul
mesh_terms: D000628:Aminophylline / Q000627:therapeutic use; D001049:Apnea / Q000209:etiology / Q000628:therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000209:etiology / Q000628:therapy; D011175:Positive-Pressure Respiration / Q000379:methods; D012121:Respiration, Artificial / Q000379:methods
chemical_list: D001993:Bronchodilator Agents; D000697:Central Nervous System Stimulants; D000628:Aminophylline; D002110:Caffeine